In Re Abbott Laboratories Derivative Shareholders Litigation

U.S. Court of Appeals, Seventh Circuit · Decided 2003-05-27

Cited by 102 later decision(s) in our corpus · see the citation network in Lexace

Open in Lexace · Ask the AI about this case

From the opinion

HARLINGTON WOOD, JR., Circuit Judge. This shareholder derivative suit arises from a consent decree between Abbott Laboratories (“Abbott”) and the Food and Drug Administration (“FDA”). The action was brought in federal court on behalf of Abbott shareholders against Abbott’s board of directors alleging that the directors breached their fiduciary duties and are liable under Illinoi…

Read the full opinion (source) ↗


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Citation figures are counts of later citing opinions in our corpus and may be incomplete; always read and Shepardize the full opinion before relying on it.